Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enthesitis-Related Arthritis, Juvenile”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableUnknownNCT02684695
What this trial is testing

Juvenile Arthritis Quantitative Imaging

Who this might be right for
Arthritis, Juvenile IdiopathicEnthesitis-Related Arthritis, Juvenile
University College London Hospitals 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Looking for participantsNCT06869551
What this trial is testing

Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb 60
Not applicableLooking for participantsNCT04540432
What this trial is testing

Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment

Who this might be right for
Spondylarthropathies
Centre Hospitalier Universitaire de Nīmes 25
Not applicableLooking for participantsNCT06383195
What this trial is testing

The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

Who this might be right for
Enthesitis Related ArthritisEnthesitis Related Arthritis, Juvenile
Hacettepe University 40
Large-scale testing (Phase 3)Study completedNCT00962741
What this trial is testing

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Arthritis, Juvenile Idiopathic
Pfizer 127
Large-scale testing (Phase 3)Study completedNCT01421069
What this trial is testing

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Juvenile Idiopahtic Arthritis
Pfizer 109
Large-scale testing (Phase 3)Active Not RecruitingNCT04527380
What this trial is testing

Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Eli Lilly and Company 101
Early research (Phase 1)Looking for participantsNCT06751238
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Who this might be right for
Juvenile Psoriatic Arthritis
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01166282
What this trial is testing

The Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis

Who this might be right for
Enthesitis Related Arthritis (ERA)
AbbVie (prior sponsor, Abbott) 46
Large-scale testing (Phase 3)Study completedNCT03031782
What this trial is testing

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis-related Arthritis
Novartis Pharmaceuticals 86
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableNot Yet RecruitingNCT06766552
What this trial is testing

A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Who this might be right for
Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)Nr-axSpA+5 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 10,000
Large-scale testing (Phase 3)Looking for participantsNCT06100744
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Who this might be right for
Juvenile Psoriatic Arthritis
AbbVie 40
Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Not applicableLooking for participantsNCT01422694
What this trial is testing

Natural History and Development of Spondyloarthritis

Who this might be right for
ArthritisSpondylitis, Ankylosing
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Not applicableLooking for participantsNCT02418442
What this trial is testing

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Who this might be right for
Rheumatic Joint Disease
Duke University 20,000
Large-scale testing (Phase 3)Study completedNCT03769168
What this trial is testing

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Novartis Pharmaceuticals 55
Load More Results